Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats

Julio C. Sartori-Valinotti, Marcia R. Venegas-Pont, Babbette B. LaMarca, Damian G. Romero, Licy L. Yanes, Lorraine C. Racusen, Allison V. Jones, Michael J. Ryan, Jane F. Reckelhoff

Research output: Contribution to journalArticle

Abstract

Postmenopausal women (PMW) are at greater risk for salt-sensitive hypertension and insulin resistance than premenopausal women. Peroxisome-proliferator-activated receptor-gamma (PPARγ) agonists reduce blood pressure (BP) and insulin resistance in humans. As in PMW, ovariectomy (OVX) increases salt sensitivity of BP and body weight in Dahl salt-sensitive (DS) rats. This study addressed whether rosiglitazone (ROSI), a PPARγ agonist, attenuates salt-sensitive hypertension in intact (INT) and OVX DS rats, and if so, whether insulin resistance, nitric oxide (NO), oxidative stress, and/or renal inflammation were contributing mediators. Telemetric BP was similar in OVX and INT on low salt diet (0.3% NaCl), but was higher in OVX than INT on high salt (8% NaCl). ROSI reduced BP in OVX and INT on both low and high salt diet, but only attenuated salt sensitivity of BP in OVX. Nitrate/nitrite excretion (NOx; index of NO) was similar in INT and OVX on low salt diet, and ROSI increased NOx in both groups. High salt diet increased NOx in all groups but ROSI only increased NOx in OVX rats. OVX females exhibited insulin resistance, increases in body weight, plasma leptin, cholesterol, numbers of renal cortical macrophages, and renal MCP-1 and osteopontin mRNA expression compared to INT. ROSI reduced cholesterol and macrophage infiltration in OVX, but not INT. In summary, PPARγ activation reduces BP in INT and OVX females, but attenuates the salt sensitivity of BP in OVX only, likely due to increases in NO and in part to reductions in renal resident macrophages and inflammation.

Original languageEnglish (US)
Pages (from-to)794-799
Number of pages6
JournalSteroids
Volume75
Issue number11
DOIs
StatePublished - Nov 1 2010

Keywords

  • Hypertension
  • Inflammation
  • Menopause
  • Ovariectomy
  • Oxidative stress

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology
  • Pharmacology
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats'. Together they form a unique fingerprint.

  • Cite this

    Sartori-Valinotti, J. C., Venegas-Pont, M. R., LaMarca, B. B., Romero, D. G., Yanes, L. L., Racusen, L. C., Jones, A. V., Ryan, M. J., & Reckelhoff, J. F. (2010). Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats. Steroids, 75(11), 794-799. https://doi.org/10.1016/j.steroids.2009.10.010